About Us

Our Story

Forest Devices is a medical device startup located in Pittsburgh, Pennsylvania. We are the creators of ALPHASTROKE, the first stroke and Large Vessel Occlusion (LVO) detection device that can potentially be used by first responders to triage patients directly to the right hospital.

By re-purposing established technology, our team is developing a novel and objective stroke detection method. It would enable early and fast triage so stroke patients go to the appropriate level of care. The gold-standard of treatments are time-limited and early interventions increase effectiveness. With missed interventions annually due to inadequate stroke detection and triage, we are determined to become the new standard of care.

All of our team members have been impacted by stroke to friends or family members. At Forest Devices, we will change the way the world approaches stroke detection.

Easy to Use

The Team


Matt Kesinger

Chief Science Officer, Founder

Matt received his M.S. in Healthcare Policy and Management from Carnegie Mellon University and published research on the difficulties of pre-hospital providers diagnosing stroke after being an EMT in Boston.


Dan Willis

Chief Technology Officer, Co-Founder

Dan received his B.S. in Electrical and Computer Engineering from The Ohio State University.


Carmelo R. Montalvo

Chief Operating Officer, Co-Founder

Carmelo received his M.S. in Healthcare Policy and Management from Carnegie Mellon University.


Steve Morrow

Chief Financial Officer, Co-Founder

Steve has spent over half of his 15 years experience in strategy, market analysis, project analysis, and operations in the Life Sciences industry.


Alex Basalyga

Lead DevOps Engineer

Liam Berti

Senior Data Scientist

Nick Zak

Director of Operations

Denis Olsen

Executive Director - Operations and Commercial Management

Disciplined, high performance orientated Senior Executive with experience in varied functional disciplines including Production Operations, Maintenance, Engineering, Quality, Commercialization Processes and Service. Background also includes International organic start-up business projects, identification of acquisition targets, working with Private Equity partners, in-depth financial analysis, and leading due diligence processes required to support acquisition projects for business growth targets WW.


Peter Cleber

Director, Forest Devices Europe B.V.

Peter is CEO & Founder of IdeogeniQ, a business based in the Netherlands which supports medical device companies accessing European healthcare markets with selection and management of distributors and distribution channels in order to achieve structural and sustainable growth. IdeogeniQ accompanies companies through all stages of their business development efforts, including product registration, distributor selection, manufacturer representation, sales & marketing strategies, warehousing & supply chain infrastructures and the management of direct and indirect sales & marketing operations in Europe.


John Tedeschi

Executive Director - Global Commercialization

John is a proven marketing and sales executive with a distinguished career of delivering consistent, progressive results. He has demonstrated success in customer focused marketing and sales, distributor sales, corporate accounts, and building start-up sales organizations in Europe and Japan. Managing sales and marketing departments, John has delivered brand growth and functional excellence with North American and International sales and marketing teams growing sales from $17 million to more than $600 million in annual revenue over his career.

Board of Directors


Steve Fleck, M.B.A.

Executive Chair & Interim CEO

Steve Fleck is an experienced entrepreneur focused on disruptive healthcare technologies. Steve founded Careform Inc., the leading provider of technology-enabled patient services for the pharmaceutical industry. Careform was acquired in November 2017 by ConnectiveRx, a Genstar Capital portfolio company. Steve served as Chief Operating Officer of ConnectiveRx through 2019, leading the company’s operations, product, IT, and data analytics organizations. Steve was previously the co-founder of ClearCount Medical Solutions, where he led development of innovative patient safety for the operating room. ClearCount was acquired by Stryker in 2014. Steve holds fourteen patents on medical technologies. He earned his MBA from Carnegie Mellon University and a BS in Applied and Engineering Physics from Cornell University. Steve is an active early-stage investor and serves on advisory boards of AlphaLabs Health, Waldron Capital Management, and Birgo Capital.

Ashok headshot

Ashok Rao


Ashok Rao is a decorated Serial Entrepreneur with five successful high technology start-ups of his own. Currently, he is an Angel Investor, investing in several start-ups, mentoring their founders, and serving on their boards. He has led and contributed to the successful exit of several startups. From 2014-2017, Ashok was the Chairman of Adhesys Medical, Inc. That year, he led the sale and acquisition of Adhesys to Grunenthal in April 2017. He now serves as the Chairman of their Advisory Board. In addition, Rao is the Chairman of BioMed X Innovation Center in Heidelberg, Germany, and Houston, TX and is the Principal Investor & Chairman of SiNode Systems.


David Motley, M.B.A.


Mr. Motley is Co-founder and General Partner at BlueTree Venture Fund, a Pittsburgh-based venture capital firm investing in med-tech and IT companies at the Series B stage. He is also Managing Director at Headwaters SC, a mid-cap investment banking firm that provides sell side and buy side transaction support, advisory services and growth capital to business-owning families. Previously, Mr. Motley held the position of Vice President and General Manager at Covidien, Inc. Surgical Devices, where his principal responsibilities were franchise management, portfolio management and strategy for its $2 billion portfoli of surgical products.


Ian Colrain, Ph.D.


Ian Colrain, PhD is President of SRI Biosciences, one of the largest research organizations in the United States. SRI partners with organizations worldwide to bring new medicines and devices to market through basic research, technology discovery, preclinical development and clinical translation. Ian is an internationally recognized leader in sleep research using EEG and evoked potentials. He has published over 300 articles, chapters, and abstracts, and he is a member of the Medical Advisory Board for Compumedics Pty. Ltd., a leading manufacturer of EEG-based diagnostic equipment. He has led the technical diligence for venture investments in numerous neurology companies.He was the clinical senior research fellow in the Stanford University Sleep Disorders Center and held tenured faculty appointments at Auckland University in New Zealand and The University of Melbourne in Australia where he is currently a professorial fellow. He served as a reserve officer in the Australian Army Psychology Corps and earned the Australian Defence Medal.

Clinical Advisors


W. Frank Peacock, MD, FACEP, FACC

Chief Medical Officer

W. Frank Peacock IV, MD, FACEP, FACC is a Professor of Emergency Medicine, Associate Chair, and Research Director for the department of Emergency Medicine at the Baylor College of Medicine, in Houston, Texas. He serves as a member of the Accreditation Management Board for the American College of Cardiology, as well as on the NCDR Action Registry-Get With The Guidelines Research and Publications Subcommittee. With over 500 peer reviewed publications, predominantly on heart failure and acute coronary syndromes, Dr. Peacock is also the co-editor of the textbooks Cardiac Emergencies, Short Stay Management of Heart Failure, Short Stay Management of Chest Pain, and Short Stay Management of Atrial Fibrillation.

Screen Shot 2017-03-20 at 11.48.37 AM

Mark Wholey, M.D.

Emeritus Chairman Radiology, UPMC – Shadyside Hospital

Dr. Wholey is Director of the Center for Vascular and Neurovascular Interventions and Allegheny Health Network. He specializes in peripheral vascular procedures and is considered a pioneer in his field, having founded medical technology companies, developed popular medical devices and treated thousands of patients. He is a co-founder of EndoTex and Embolic Protection, both acquired by Boston Scientific Corp., and of Medrad. He is also the inventor of many medical devices, including the Wholey Wire.


Lawrence Wechsler, M.D.

Chair of Neurology, Pennsylvania Hospital

Dr. Wechsler is Chair of Neurology at Pennsylvania Hospital. He is the Founder of the University of Pittsburgh Medical Center Stroke Institute and has been very active in the treatment of stroke and its debilitating effects. Dr. Wechsler has served as local principal investigator for national and international clinical trials testing new treatments for acute stroke.

Our Business Advisors


Penn Krause, FACHE

Regional VP, American Physicians Partners

Penn Krause is a healthcare operations and business development leader with management experience in hospitals and startups. As a member of the Community Health Systems' (CHS) senior team, Penn helped lead CHS through rapid growth and IPO. He became a champion of IT while CEO at Mercy Health System, which earned recognition as one of the “Top 100 Most Wired.” Mr. Krause possess an entrepreneurial knowledge of the healthcare industry and delivering new technologies, having developed and grown health IT startups which serve some of the nation's premier health systems.

Our Partners

medtech innovator
logo avenu
logo life sciences greenhouse
logo innovation works
logo alphalab gear
logo cmu
logo ascender